PULSION Medical Systems SE

Equities

PUS

DE0005487904

Medical Equipment, Supplies & Distribution

End-of-day quote BOERSE MUENCHEN Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
17.5 ^EUR	0.00%		0.00%	+9.38%

2023	PULSION Medical Systems SE Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	PULSION Medical Systems SE Reports Earnings Results for the Full Year Ended December 31, 2021	CI

PULSION Medical Systems SE Increased Earnings Guidance for the Full Year 2012

January 14, 2013 at 06:11 am EST

PULSION Medical Systems SE increased earnings guidance for the full year 2012. For the year, the company expects revenues to be in the range of €34.5 million to €34.7 million, EBITDA at least €11.5 million, EBIT of €9.5 million and diluted earnings per share of 75 cents to 81 cents.

Latest news about PULSION Medical Systems SE

PULSION Medical Systems SE Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-03	CI
PULSION Medical Systems SE Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-26	CI
Pulsion Medical Systems Se Reports Earnings Results for the Full Year Ended December 31, 2020	21-06-14	CI
PULSION Medical Systems SE's Equity Buyback announced on May 16, 2012 has expired.	17-05-14	CI
Tranche Update on PULSION Medical Systems SE's Equity Buyback Plan announced on May 16, 2012.	15-09-07	CI
Maquet Spain, S.L., Sociedad Unipersonal acquired PULSION Medical Systems Iberica SL from PULSION Medical Systems SE.	15-08-19	CI
Diagnostic Green GmbH acquired Perfusion Imaging business division from PULSION Medical Systems SE (DB:PUS).	15-05-10	CI
Maquet And PULSION Announce Distribution Agreement For The PiCCO(R) And ProAQT(R) Hemodynamic Product Lines	14-10-07	CI
PULSION Medical Systems SE Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Fiscal 2014	14-05-12	CI
PULSION Medical Systems SE Proposes Distribution of Dividend for the Fiscal Year 2013	14-03-28	CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012.	14-03-13	CI
Getinge AB (OM:GETI B) completed the acquisition of 78.55% stake of PULSION Medical Systems SE for approximately €110 million.	14-02-18	CI
Getinge AB (OM:GETI B) made an offer to acquire PULSION Medical Systems SE for approximately €140 million.	13-12-03	CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012.	13-11-08	CI
PULSION Medical Systems SE Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013; Provides Earnings Guidance for the Year 2013	13-11-07	CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012.	13-08-09	CI
PULSION Medical Systems SE Announces Group Financial Results for the Second Quarter and Six Months Ended June 30, 2013; Provides Earnings Guidance for the Year of 2013	13-08-08	CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012.	13-06-12	CI
Pulsion Medical Systems Se Proposes Distribution of Dividend for the Fiscal Year 2012; Proposes Special Dividend	13-03-21	CI
PULSION Medical Systems SE Reports Group Earnings Results for the Year Ended December 31, 2012	13-03-20	CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012.	13-03-10	CI
PULSION Medical Systems SE Increased Earnings Guidance for the Full Year 2012	13-01-14	CI
PULSION Medical Systems SE Reports Earnings Results for the Nine Months of Fiscal 2012; Provides Earnings Guidance for the Full Year of 2012	12-11-02	CI
PULSION Medical Systems SE Reports Group Earnings Results for the First Quarter Ended March 31, 2012	12-05-17	CI

Chart PULSION Medical Systems SE

Duration

Period

More charts

Company Profile

Pulsion Medical Systems SE is a Germany-based company that develops and markets minimally invasive physiological monitoring systems for use in intensive care stations and in operating rooms. The Company's products are used primarily to monitor blood circulatory systems in patients. Pulsion also markets disposable measuring catheters and the intravenous diagnostic dye Indocyanine Green. The Company operates worldwide. On February 19, 2014, Getinge AB secured 78.55% of the outstanding shares in Pulsion Medical Systems SE.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PULSION MEDICAL SYSTEMS SE	+9.38%	157M
ABBOTT LABORATORIES	-5.43%	182B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.38B
DEXCOM, INC.	+5.86%	52.46B
CENCORA, INC.	+8.15%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.79B

Other Medical Equipment, Supplies & Distribution